Evidence map›Paper›PMID 28521423›Full record

ArticleOncology letters2017

Molecular dysexpression in gastric cancer revealed by integrated analysis of transcriptome data.

Xiaomei Li, Weiwei Dong, Xueling Qu, Huixia Zhao, Shuo Wang, Yixin Hao, Qiuwen Li, Jianhua Zhu, Min Ye, Wenhua Xiao

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xiaomei LiDepartment of Oncology, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, P.R. China.
Weiwei DongDepartment of Oncology, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, P.R. China.
Xueling QuDepartment of Oncology, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, P.R. China.
Huixia ZhaoDepartment of Oncology, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, P.R. China.
Shuo WangDepartment of Oncology, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, P.R. China.
Yixin HaoDepartment of Oncology, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, P.R. China.
Qiuwen LiDepartment of Oncology, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, P.R. China.
Jianhua ZhuDepartment of Oncology, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, P.R. China.
Min YeDepartment of Oncology, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, P.R. China.
Wenhua XiaoDepartment of Oncology, The First Affiliated Hospital of PLA General Hospital, Beijing 100048, P.R. China.
First Affiliated Hospital of Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric cancer (GC) is often diagnosed in the advanced stages and is associated with a poor prognosis. Obtaining an in depth understanding of the molecular mechanisms of GC has lagged behind compared with other cancers. This study aimed to identify candidate biomarkers for GC. An integrated analysis of microarray datasets was performed to identify differentially expressed genes (DEGs) between GC and normal tissues. Gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were then performed to identify the functions of the DEGs. Furthermore, a protein-protein interaction (PPI) network of the DEGs was constructed. The expression levels of the DEGs were validated in human GC tissues using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). A set of 689 DEGs were identified in GC tissues, as compared with normal tissues, including 202 upregulated DEGs and 487 downregulated DEGs. The KEGG pathway analysis suggested that various pathways may play important roles in the pathology of GC, including pathways related to protein digestion and absorption, extracellular matrix-receptor interaction, and the metabolism of xenobiotics by cytochrome P450. The PPI network analysis indicated that the significant hub proteins consisted of SPP1, TOP2A and ARPC1B. RT-qPCR validation indicated that the expression levels of the top 10 most significantly dysexpressed genes were consistent with the illustration of the integrated analysis. The present study yielded a reference list of reliable DEGs, which represents a robust pool of candidates for further evaluation of GC pathogenesis and treatment.

Indexed as

differentially expressed genesexpression profilegastric cancerintegrated analysisreverse transcription-quantitative polymerase chain reaction

Identifiers

PMID28521423
PMCPMC5431188
OpenAlexW2594672060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.